
### [MONDO:0017896](http://purl.obolibrary.org/obo/MONDO_0017896)
**Label:** familial nonmedullary thyroid carcinoma

**Subclasses:** [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), 

**Corr. equiv. classes:** [OMIM:616534](http://purl.obolibrary.org/obo/OMIM_616534), [OMIM:603386](http://purl.obolibrary.org/obo/OMIM_603386), [OMIM:603744](http://purl.obolibrary.org/obo/OMIM_603744), [OMIM:616535](http://purl.obolibrary.org/obo/OMIM_616535), [OMIM:188550](http://purl.obolibrary.org/obo/OMIM_188550), [OMIM:188470](http://purl.obolibrary.org/obo/OMIM_188470), [Orphanet:319487](http://www.orpha.net/ORDO/Orphanet_319487), [OMIM:606240](http://purl.obolibrary.org/obo/OMIM_606240), 

**Class expressions from DL-Learner:**

- [HP:0040198](http://purl.obolibrary.org/obo/HP_0040198) (Non-medullary thyroid carcinoma) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0012114](http://purl.obolibrary.org/obo/HP_0012114) (Endometrial carcinoma))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0009720](http://purl.obolibrary.org/obo/HP_0009720) (Adenoma sebaceum))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0008675](http://purl.obolibrary.org/obo/HP_0008675) (Enlarged polycystic ovaries))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0007565](http://purl.obolibrary.org/obo/HP_0007565) (Multiple cafe-au-lait spots))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0005595](http://purl.obolibrary.org/obo/HP_0005595) (Generalized hyperkeratosis))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0002516](http://purl.obolibrary.org/obo/HP_0002516) (Increased intracranial pressure))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia))) 62.50%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0000717](http://purl.obolibrary.org/obo/HP_0000717) (Autism))) 62.50%
- [HP:0002890](http://purl.obolibrary.org/obo/HP_0002890) (Thyroid carcinoma) 59.20%
- [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) 53.61%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) 53.32%
- [HP:0002895](http://purl.obolibrary.org/obo/HP_0002895) (Papillary thyroid carcinoma) 53.32%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0030923](http://purl.obolibrary.org/obo/HP_0030923) (5-minute APGAR score of 3))) 53.32%
- [HP:0006731](http://purl.obolibrary.org/obo/HP_0006731) (Follicular thyroid carcinoma) and (not ([HP:0030922](http://purl.obolibrary.org/obo/HP_0030922) (5-minute APGAR score of 2))) 53.32%


